Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Latest News
Apr 15, 2014
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled...
Jan 23, 2014
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in...
Oct 7, 2013
Generics Bulletin profiles the exciting potential of Prosonix' respiratory pipeline and...
Events
4-8 May 2014
Fajardo, Puerto Rico
16-21 May 2014
San Diego, CA, USA
Terms & Conditions
© Prosonix Ltd, 2013
The Magdalen Centre   Robert Robinson Avenue   Oxford Science Park   Oxford   OX4 4GA   United Kingdom   |   Tel: +44 (0)1865 784250   |   Email: Here